News

With a vision to make affordable & quality medicines Aprazer healthcare will manufacture world class oral solid drugs at state of art WHO-GMP....

Launch Date: 30/06/2021 Aprazer Healthcare Launched PIRFEKAST (Pirfenidone) which is a medication indicated for the treatment of idiopathic pulmonary fibrosis (IPF).....

Launch Date: 26/02/21 Aprazer Healthcare Launched SUTEKAST (Sunitinib) which is a medication indicated for the treatment of rare cancer of the stomach, bowel, or esophagus called gastrointestinal.....

Launch Date: 11/01/21 Aprazer Healthcare Launched XGRAF (Tacrolimus Capsules ) which is used for the prophylaxis of organ rejection in adults and paediatric patients receiving kidney....

Launch Date: 19/12/20 Aprazer Healthcare Launched MEROAXIS (Meropenem Inj) which is a medication indicated for the treatment of susceptible infections including....

Launch Date: 07/12/20 Aprazer Healthcare Launched HQKAST (Hydroxychloroquine), which is a medication indicated for the treatment of Malaria....

Launch Date: 31/10/20 Aprazer Healthcare Launched CAPEKAST (Capecitabine) which is a medication indicated for the treatment of patients....

Launch Date: 17/10/20 Aprazer Healthcare Launched Lenvakast (Lenvatinib) which is a medication indicated for the treatment of patients....

Launch Date: 29/09/2020 Aprazer Healthcare Launched Lenakast (Lenalidomide) which is a medication indicated for the treatment of Myelodysplastic Syndromes....

Launch Date: 31/08/20 Aprazer Healthcare Launched TAMIKAST (Oseltamivir) whic...